Paper6479679
Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
Rodzynek JJ and 4 others. Gut, 1984. Cited by 18 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance. Papers, record 6479679. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6479679
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antithrombin III, plasminogen and alpha 2 antiplasmin in jaundice. Clinical usefulness and prognostic significance.
- PubMed
Topics16
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antithrombin III | Major topic |
| Jaundice | Major topic |
| Plasminogen | Major topic |
| alpha-2-Antiplasmin | Major topic |
| Adult | |
| Aged | |
| Blood Coagulation Tests | |
| Cholestasis | |
| Female | |
| Fibrinogen | |
| Humans | |
| Liver Neoplasms | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Prospective Studies |
Source PubMed
References17
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 7,461,504 | Antithrombin III versus prothrombin in liver cirrhosis. | Haemostasis | 1981 | https://conductscience.org/library/papers/7461504 | PubMed |
| 2 | 6,812,211 | Low antithrombin III in acute hepatic failure at term. | Scand J Haematol | 1982 | https://conductscience.org/library/papers/6812211 | PubMed |
| 3 | 7,146,823 | Improvement of some blood coagulation factors in cirrhotic patients treated with low doses of heparin. | Scand J Haematol | 1982 | https://conductscience.org/library/papers/7146823 | PubMed |
| 4 | 6,186,045 | Antithrombin III in rat hepatocytes. | Thromb Res | 1982 | https://conductscience.org/library/papers/6186045 | PubMed |
| 5 | 7,157,228 | Synthesis of alpha 2-antiplasmin by rat liver cells. | Thromb Res | 1982 | https://conductscience.org/library/papers/7157228 | PubMed |
| 6 | 4,120,848 | Fibrinolysis in cholestatic jaundice. | Br Med J | 1973 | https://conductscience.org/library/papers/4120848 | PubMed |
| 7 | 4,515,631 | Value of Normotest and antithrombin 3 in the assessment of liver function. | Scand J Gastroenterol Suppl | 1973 | https://conductscience.org/library/papers/4515631 | PubMed |
| 8 | 4,515,632 | Behaviour of antithrombin 3 in liver disease. | Scand J Gastroenterol Suppl | 1973 | https://conductscience.org/library/papers/4515632 | PubMed |
| 9 | 4,123,935 | Use of Normotest and Thrombotest, coagulation tests in hepatocellular disease. | Scand J Gastroenterol Suppl | 1973 | https://conductscience.org/library/papers/4123935 | PubMed |
| 10 | 5,163,179 | Metabolism of fibrinogen in cirrhosis of the liver. | J Clin Invest | 1971 | https://conductscience.org/library/papers/5163179 | PubMed |
| 11 | 4,596,237 | Intravascular coagulation in liver disease. | Annu Rev Med | 1974 | https://conductscience.org/library/papers/4596237 | PubMed |
| 12 | 131,986 | Inhibition of plasmin by normal and antiplasmin-depleted human plasma. | Thromb Res | 1976 | https://conductscience.org/library/papers/131986 | PubMed |
| 13 | 935,800 | Observations of increased levels of blood coagulation factors and other plasma proteins in cholestatic liver disease. | Scand J Gastroenterol | 1976 | https://conductscience.org/library/papers/935800 | PubMed |
| 14 | 76,519 | The alpha2-plasmin inhibitor levels in liver diseases. | Clin Chim Acta | 1978 | https://conductscience.org/library/papers/76519 | PubMed |
| 15 | 149,046 | Methods for determination of plasmin, antiplasmin and plasminogen by means of substrate S-2251. | Haemostasis | 1978 | https://conductscience.org/library/papers/149046 | PubMed |
| 16 | 7,191,149 | Effect of hepatectomy on the posttraumatic fibrinolysis inhibition and the primary fibrinolysis inhibitor in the rat. | Thromb Res | 1980 | https://conductscience.org/library/papers/7191149 | PubMed |
| 18 | 14,429,572 | Thrombotest. A new method for controlling anticoagulant therapy. | Lancet | 1959 | https://conductscience.org/library/papers/14429572 | PubMed |
Genes4
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FGB | 2,244 | PubTator's text mining | https://conductscience.org/library/genes/2244 | NCBI Gene |
| PLG | 5,340 | PubTator's text mining | https://conductscience.org/library/genes/5340 | NCBI Gene |
| SERPINC1 | 462 | PubTator's text mining | https://conductscience.org/library/genes/462 | NCBI Gene |
| SERPINF2 | 5,345 | PubTator's text mining | https://conductscience.org/library/genes/5345 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6479679
GET https://conductscience.org/api/papers/v1/6479679/authors